Novo Nordisk A/S - share repurchase programme
April 15, 2024 08:43 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 15 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Anti-obesity Drugs market is estimated to grow at a CAGR of 21.2% by 2034: Visiongain
April 12, 2024 11:17 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Anti-obesity Drugs Market Report 2024-2034: Forecasts by Drug Type (Prescription, OTC), by Mechanism of Action (Glucagon Like Peptide GLP-1 Agonists,...
Novo Nordisk A/S - share repurchase programme
April 08, 2024 09:40 ET
|
Novo Nordisk A/S
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 08 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No...
Glucagon-Like Peptide 1 (GLP-1) Agonist Market To Reach USD 21.2 Billion By 2032, Report By DataHorizzon Research
April 08, 2024 07:30 ET
|
DataHorizzon Research
Fort Collins, Colorado, April 08, 2024 (GLOBE NEWSWIRE) -- Growing cases of diabetes and obesity trigger the need for GLP-1 receptor agonists Type 2 diabetes and obesity represent critical health...
Novo Nordisk A/S - share repurchase programme
April 02, 2024 06:56 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 2 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Fungicides Market Size is projected to reach USD 23,393.85 million by 2031, growing at a CAGR of 4.6%: Straits Research
March 28, 2024 11:55 ET
|
Straits Research Private Limited - Reed Intelligence
New York, United States, March 28, 2024 (GLOBE NEWSWIRE) -- Modern crop protection against fungal diseases must include fungicides. Due to changes in farming practices and technological...
Hemophilia B Drug Market Size and Share to Grow by 2032, Assesses DelveInsight | Key Emerging Therapies - CSL222, SerpinPC, AskBio009, PF-06838435/fida, Marstacimab, FLT180a, Concizumab, Fitusiran
March 27, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 27, 2024 (GLOBE NEWSWIRE) -- Hemophilia B Drug Market Size and Share to Grow by 2032, Assesses DelveInsight | Key Emerging Therapies - CSL222, SerpinPC, AskBio009,...
Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight
March 25, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 25, 2024 (GLOBE NEWSWIRE) -- Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight The rise in the number of people suffering from cirrhosis can be...
Global Smart Insulin Pens Market Report 2024, Featuring Profiles of Companion Medical, Emperra, Eli Lilly, Bigfoot Biomedical, Diamesco, Pendiq, Medtronic, Diabnext, Diabecare and Capillary Biomedical
March 25, 2024 12:13 ET
|
Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Global Smart Insulin Pens Market" report has been added to ResearchAndMarkets.com's offering.The global smart insulin pens market accounted for USD...
Novo Nordisk A/S - share repurchase programme
March 25, 2024 07:58 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 25 March 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...